Pandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patients

Fatma Gül Yurdakul; Hatice Bodur; Ahmet Kıvanç Cengiz; Yunus Durmaz; Mehmet Tuncay Duruöz; Taciser Kaya; Sertaç Ketenci; Nihan Cüzdan; Tuba Güler; Zafer Günendi; Selda Sarıkaya; Erhan Çapkın; Mustafa Erkut Önder; Meltem Alkan Melikoğlu; Rengin Güzel; Nesrin Şen; Ata Bora Ayna; Özgür Akgül; Erhan Eser; Şebnem Ataman

doi:10.46497/archrheumatol.2024.10313

Abstract

This study aimed to assess the clinical outcomes and risk factors for severe coronavirus disease 2019 (COVID-19) in patients with inflammatory rheumatic disease (IRD) of a national cohort.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yurdakul et al. (2024) studied this question.

synapsesocial.com/papers/68e72ce0b6db6435876a6a26 https://doi.org/10.46497/archrheumatol.2024.10313

View at Publisher

Ask AI

Bookmark

Share

Pandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patients

Abstract

Discussion

Cite This Study

Pandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patients

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from Archives of Rheumatology

Keep reading

More related papers

More from Archives of Rheumatology